UK markets closed

Biocartis Group NV (0R72.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
1.7340+0.0143 (+0.83%)
At close: 05:40PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.27
52-week change 3-75.69%
S&P500 52-week change 326.49%
52-week high 31.7200
52-week low 30.2865
50-day moving average 30.3332
200-day moving average 30.5270

Share statistics

Avg vol (3-month) 374.38k
Avg vol (10-day) 32.74k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 886.57M
% held by insiders 16.59%
% held by institutions 126.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin -111.58%
Operating margin (ttm)-70.10%

Management effectiveness

Return on assets (ttm)-24.03%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)60.82M
Revenue per share (ttm)0.78
Quarterly revenue growth (yoy)10.60%
Gross profit (ttm)N/A
EBITDA -37.02M
Net income avi to common (ttm)-67.87M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)25.18M
Total cash per share (mrq)0.27
Total debt (mrq)152.25M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.15
Book value per share (mrq)-0.58

Cash flow statement

Operating cash flow (ttm)-49.96M
Levered free cash flow (ttm)-36.09M